
Ovarian clear cell carcinoma is a rare histological type of epithelial ovarian cancer that is typically resistant to chemotherapy and is historically associated with poor prognosis for patients.

Ovarian clear cell carcinoma is a rare histological type of epithelial ovarian cancer that is typically resistant to chemotherapy and is historically associated with poor prognosis for patients.

Relatlimab, a human LAG-3 blocking antibody, plus nivolumab, elicited superior progression-free survival in patients with advanced melanoma compared to nivolumab alone.

Patients with early-stage breast cancer who have low vitamin D counts may be at risk of developing chemotherapy-induced peripheral neuropathy.

Reducing ribociclib dosing by 200 mg or 400 mg did not affect overall survival in patients with hormone receptor–positive, HER2-negative, advanced breast cancer.

Advocacy and opposition continue to grow regarding the National Organization of Nurse Practitioner Faculties’ goal of requiring the Doctor of Nursing Practice degree (DNP) for entry-level nurse practitioners.

Strategic tips for achieving a Nurse Practitioner certification and advancing your nursing career.

In this episode of “The Vitals,” Mark Honor, PA-C, discusses adverse event management in patients receiving different therapeutic options.

Experts from Roswell Park developed a dosing guide for the prescription of buprenorphine as treatment for chronic pain.

The COVID-19 pandemic has affected oncology practice in many ways. What will safe treating look like moving forward?

Mark Honor, PA-C, highlights best adverse event management practices for patients undergoing chemotherapy and immune-based treatment.

Patients who underwent surveillance with bioimpedance spectroscopy were less likely to develop chronic breast cancer–related lymphedema compared with patients who were assessed with tape measure.

A secondary analysis of the COACH study revealed that a geriatric assessment–guided intervention increased the number of comorbidity-related discussions between patients and providers.

In this episode of “The Vitals,” 2 veteran oncology nurses discuss the value of mentorship—particularly for novice nurses.

New data support smoking cessation for patients with lung cancer following their diagnosis.

An expert from Mount Sinai Hospital comments on potential new ruxolitinib combinations to treat patients with myelofibrosis and MPNs.

Patient advocate Jill Feldman led the development of the language guide to help promote patient-centered, stigma-free language across the lung cancer community.

Kathy Burns, MS, APRN-CNS, AGCNS-BC, of the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, comments on the importance of self-awareness as an oncology nurse when working to overcome one’s implicit bias.

Bruce Carleton, PharmD, FCP, FISPE, discusses the implications of research findings indicating that very young children are at a higher risk of cisplatin-induced hearing loss.

An expert discusses the value of enrolling patients with soft tissue sarcoma in histologically specific clinical trials.

Jessica MacIntyre, APRN, NP-C, AOCNP, explains how Hematology/Oncology Nurse Practitioner Fellowship at Sylvester Comprehensive Cancer Center prepares fellows for success.

Andrew Kass, MSN, RN, AGNP-C, AOCNP, discusses the impact fatigue can have on patients with cancer and how oncology nurses and APPs can help their patients address this common adverse event.

Seventy-three percent of advanced practice providers reported that they are interested in becoming more involved with clinical trials.

“Each step along the way has really helped me grow professionally, not just as a clinician, but as a whole practitioner, to make my transition to practice a lot easier and make me more comfortable… it’s really an invaluable experience.”

Stephanie Jackson, DNP, MSN, RN, AOCNS, BMTCN, Oncology Nursing News co-editor in chief, discusses the importance of NCCN guidelines in prescribing medications for patients with chronic leukemia. .

Jessica MacIntyre, executive director of clinical operations at Sylvester Comprehensive Cancer Center, explains how the small market for experienced oncology nurse practitioners prompted their institution to design a successful Hematology/Oncology Nurse Practitioner Fellowship.

“It is not a ‘one and done kind of thing.” It is very important to implement these skills throughout the community. It's a practice. It's a behavioral change.”

The Hematology/Oncology Nurse Practitioner Fellowship is a yearlong program which seeks to train those who have recently received their NP certification.

The Oncology Nurse Practitioner Fellowship at Sylvester Comprehensive Cancer Center exposes fellows to the gamut of oncology care and teaches the skills they need to succeed.

Nurse practitioners play a key role in prescribing cancer drugs and educating patients about their therapies.

Music can help alleviate stress and bring something familiar into an unfamiliar medical procedure.